Skip to main content
Fig. 3 | BMC Cancer

Fig. 3

From: Androgen deprivation therapy during and after post-prostatectomy radiotherapy in patients with prostate cancer: a case control study

Fig. 3

Comparison of biochemical recurrence (BCR)-free survival form radiotherapy date with respect to duration of concurrent androgen deprivation therapy (ADT). Patients with < 12 months of concurrent ADT showed poorer 5-year BCR-free survival rates than those with longer-term (≥12 months) ADT, although the difference failed to reach statistical significance (p = 0.232)

Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us